Intravenous thrombolysis for acute ischemic stroke in centenarians
- PMID: 33909269
- DOI: 10.1007/s41999-021-00494-4
Intravenous thrombolysis for acute ischemic stroke in centenarians
Abstract
Purpose: The benefit of intravenous alteplase is well established for patients with disabling stroke symptoms regardless of age, although data on outcomes in centenarian patients are scarce. We present our experience in patients beyond 100 years.
Methods: Descriptive study including centenarians from our single-centre prospective registry who underwent intravenous thrombolysis with alteplase for acute ischemic stroke in our tertiary university hospital. Clinical variables and functional outcome at 3 months were collected.
Results: Four patients, all women, functionally independent (mRS ≤ 2) were included. Treatment with alteplase was applied within 4.5 h of stroke onset. One patient complicated with pneumonia and died. Two patients were functionally independent (mRS ≤ 2) at discharge, while the third was partially dependent (mRS of 3 at discharge), improving after 3 months, (mRS 2). No serious hemorrhagic or systemic adverse events were registered.
Conclusion: In our experience, intravenous thrombolysis may be beneficial and should be considered in patients over 100 years old with no previous disability.
Keywords: Acute ischemic stroke; Centenarians; Intravenous thrombolysis; Oldest-old.
© 2021. European Geriatric Medicine Society.
References
-
- Wilkins E, Wilson L, Wickramasinghe K et al. (2017) European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network. http://www.ehnheart.org/cvd-statistics/cvd-statistics-2017.html . Accessed 1 Dec 2020
-
- Stroke Alliance for Europe (SAFE) (2017) The burden of stroke in Europe: The challenge for policy makers. SAFE. https://www.stroke.org.uk/sites/default/files/the_burden_of_stroke_in_eu... . Accessed 1 Dec 2020
-
- Wafa HA, Wolfe CDA, Emmett E et al (2020) Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke 51(8):2418–2427. https://doi.org/10.1161/STROKEAHA.120.029606 - DOI - PubMed - PMC
-
- United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2019 revision. https://population.un.org/wpp/ . Accessed 1 Dec 2020
-
- National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1587 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical